Process development and validation of expanded regulatory T cells for prospective applications: an example of manufacturing a personalized advanced therapy medicinal product

Abstract Background A growing number of clinical trials have shown that regulatory T (Treg) cell transfer may have a favorable effect on the maintenance of self-tolerance and immune homeostasis in different conditions such as graft-versus-host disease (GvHD), solid organ transplantation, type 1 diab...

詳細記述

書誌詳細

主要な著者:	Cristiana Lavazza, Silvia Budelli, Elisa Montelatici, Mariele Viganò, Francesca Ulbar, Lucia Catani, Marta Giulia Cannone, Sara Savelli, Elisa Groppelli, Lorenza Lazzari, Roberto M. Lemoli, Matteo Cescon, Gaetano La Manna, Rosaria Giordano, Tiziana Montemurro
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2022-01-01
シリーズ:	Journal of Translational Medicine
主題:	ATMP GMP process development Process validation
オンライン･アクセス:	https://doi.org/10.1186/s12967-021-03200-x
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!